Rob Pupelis, Chief Executive Officer, Spectros Medical Devices, A DotCom Magazine Exclusive Interview
About Rob Pupelis and Spectros Medical Devices:
Rob began his career in the medical device industry at Medical Alliance, Inc. in 1995. In an effort to learn every aspect of the business, he crossed over from sales into management and was awarded Regional Operations manager of the year in 2000. In 2002, he founded AAI working with multiple manufacturers as a top distributor with a focus on the Plastic & Reconstructive Surgery market. In 2017 he spearheaded efforts to purchase Spectros with a goal to take the T-Stat technology to the next level and expand Its clinical use both in the U.S. and around the world.
Spectros Medical Devices
Spectros Medical Devices Inc. makes advanced molecular sensing devices and software which shed light on tissue health and diseases related to vascular performance.
We are a private company focused on developing life changing consumer and medical devices based on in-vivo molecular optical technologies, including clinical devices for detection of ischemia, systemic perfusion, and vascular performance.
Our advanced T-Stat Tissue Oximeter utilizes innovative optical technology, with groundbreaking use of white LEDs that speed diagnosis, enable real-time therapies, reduce complications, and lower costs.
Our focus remains on improving patient outcomes, a dedication to manufacturing devices that are built on the most advanced and proven technology, while providing the highest level of service.
It is our mission to provide trusted medical devices that improve the lives of all people who require medical treatment. Our continued dedication to researching and understanding the world of medicine and the diseases that we face today is what drives our commitment to our patients.